Pantoprazol Aurobindo (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurobindo, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Pantoprazol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Aurobindo is a proton pump inhibitor that addresses conditions linked to excess gastric acid secretion. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates healing of erosions caused by acid exposure. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with this rare endocrine tumor. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk.

Pantoprazol Aurobindo is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling, rash. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme elevation: abnormal liver function tests.

Before starting Pantoprazol Aurobindo, consider the following safety points. - Assess renal function: dose adjustment may be needed in severe impairment. - Review liver health: monitor if pre‑existing hepatic disease exists. - Evaluate long‑term use: weigh benefits against potential bone fracture risk. - Pregnancy and lactation: use only if clearly needed. - Concomitant medications: check for interactions that may affect acid suppression. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several medicines.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: modest increase in serum concentration. - Oral contraceptives: possible reduction in efficacy.